Benefits of a 2nd comparative analyze were documented by Flinn et al. This is the phase III randomized Intergroup trial evaluating FC program versus FAMP on your own in 278 clients acquiring their initial chemotherapy program for B-CLL. Dosages of FC routine have been similar to the 1st study. For https://everettx111lwh4.blognody.com/profile